Skip to main content
. 2023 Jan 9;12:1037964. doi: 10.3389/fonc.2022.1037964

Figure 6.

Figure 6

The effect of lazertinib and amivantamab on migration and proliferation of patient’s lung adenocarcinoma cells. (A) Scratch assay shows lazertinib inhibits migration ability of lung adenocarcinoma cells better than amivantamab; (B) Colony-forming unit assays shows lazertinib inhibits lung adenocarcinoma cell proliferation ability more than amivantamab. *p < 01, ***p < 0.001.